Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Restenosis Stent Study (REST) confirms lower reintervention for stents

This article was originally published in Clinica

Executive Summary

Bleeding complications are twice as common in heparinised stent patients but PTCA still requires more reinterventions, show early data from the multinational Restenosis Stent study, REST. Dr Raimund Erbel of the University of Essen in Germany said interim analysis of the first 200 patients to complete six months follow up in the 18-centre study showed an average difference of 0.24 mm in minimum luminal diameter (MLD) in the favour of stent patients. However, 12.2% of the stent patients suffered from bleeding complications compared with only 5.9% of those who underwent PTCA. As a result the average hospital stay for those receiving stent treatment was 5.8 days while PTCA patients left after 3.2 days.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087718

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel